Related Experiment Videos
Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis
R D Grutzmacher1, R S Foster, L S Feiler
1Department of Ophthalmology, University of California, Davis, USA.
American Journal of Ophthalmology
|September 1, 1995
Abstract
Purpose:
We studied the efficacy of topically applied lodoxamide tromethamine 0.1% in the treatment of superior limbic keratoconjunctivitis.
Methods:
Three patients with clinical findings of bilateral superior limbic keratoconjunctivitis. were treated with topical lodoxamide tromethamine four times daily in both eyes.
Results:
While the patients were taking lodoxamide tromethamine, symptoms and objective findings resolved.
Conclusions:
Topically applied lodoxamide tromethamine 0.1% is useful in the treatment of superior limbic keratoconjunctivitis. There may be a role for mast cell stabilizers in the treatment of this disorder.